Placebo Neuroepo multisession
Resting-state EEG recorded from patients with Parkinson's disease enrolled in a double-blind, randomized, placebo-controlled trial of Neuroepo, an erythropoietin formulation with low sialic acid content. Recordings were acquired before and six months after drug administration in Neuroepo (n=15) and placebo (n=10) groups. The dataset supports qualitative EEG abnormality ratings and quantitative source-level EEG analysis, and is shared as raw EEG in BIDS format.
- Participants
- 10
- Size
- 121 MB
- Version
- vv1.0.0
- Updated
- Nov 11, 2026